Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The efficacy of moclobemide (300–450 mg7sol;day) was compared with fluoxetine (20–40 mg/day) in a double‐blind, multicentre study in 209 patients with new episodes of depression selected from 612 consecutive depressed patients representative of those consulting psychiatric services in Finland. Antidepressant efficacy was assessed with the Hamilton Depression Rating Scale (HDRS), Montgomery‐Åsberg Depression Rating Scale and Clinical Global Impression (CGI). The Medical Outcome Study Short‐form General Health Survey (SF‐20) and 15D Measure of Quality of Life were used to measure effectiveness in terms of health‐related quality of life. Efficacy was evident with both drug treatments, with 67% in the moclobemide group and 57% in the fluoxetine group having a reduction in HDRS of more than 50%. Similarly, 77% of the patients in the moclobemide group and 67% in the fluoxetine group were assessed on the CGI as much better or very much better after 6 weeks of treatment. The most commonly reported adverse events were nausea, other gastrointestinal symptoms, nervousness, dizziness and sleep disorders. Nausea was significantly more common in the fluoxetine group and was found especially in women. Premature terminations of treatment were 18% in the moclobemide and 21% in the fluoxetine group. A significant change for the better in quality of life was found in both treatment groups, even at week 2 but especially after 6 weeks of treatment. Improvement was not only seen in dimensions measuring depression or mental health but also in other dimensions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339
The Functioning and Well-being of Depressed Patients: Results From the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.1989.03430070062031 · Cited by 2,130
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399 · cited 1×
“A fairly frequent use of hypnotics could also explain an unexpected low rate of sleep disorders and possibly the low drop-out rate (7).”
Background
Cited by
The Journal of Mental Health Policy and Economics
(2006) · The Journal of Mental Health Policy and Economics · doi:10.1002/(issn)1099-176x · Cited by 1,243
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612
Comparative responsiveness of generic and specific quality-of-life instruments
Wiebe, S., Guyatt, G., Weaver, B., Matijevic, S., & Sidwell, C. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00537-1 · Cited by 573
Andrews, G., Issakidis, C., Sanderson, K., Corry, J., & Lapsley, H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.526 · Cited by 560
A review of the use of health status measures in economic evaluation.
Brazier, Deverill, Green, Harper, & Booth (1999) · Health Technology Assessment · doi:10.3310/hta3090 · Cited by 413
Metadata
- Authors
- Lonnqvist, J., Sintonen, H., Syvälahti, E., Appelberg, B., Koskinen, T., Mannikko, T., Mehtonen, O. ‐., Naarala, M., Sihvo, S., Auvinen, J., & Pitkanen, H.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 1994-06
- Volume
- 89
- Issue
- 6
- Pages
- 363-369
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2075476000
- Cited by
- 80
- References
- 3
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine. https://app.cochat.ai/papers/10.1111/j.1600-0447.1994.tb01530.x
- The paper
- Lonnqvist, J., Sintonen, H., Syvälahti, E., Appelberg, B., Koskinen, T., Mannikko, T., Mehtonen, O. ‐., Naarala, M., Sihvo, S., Auvinen, J., & Pitkanen, H. (1994). Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1994.tb01530.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.